QualityDipStocks / Finance
Berkshire Hathaway BRK-B
Not in a dip: trading near its 52-week high.
A quality company trading above our fair value estimate, 6% over its Market Value.
- Fair value est.
- $478.54−12%
- Market Value
- $513.87price +6%
- Off 52-wk high
- −1%
- Risk vs market
- Lowbeta −0.04
3 bullish · 5 bearish See why
Key levels
Every level vs today’s $542.49
- 52-wk lowlowest close, 1 year$465.40−14.2%
- Fair value est.base case$478.54−11.8%
- Market Valueavg paid since Aug 11$513.87−5.3%
- PriceFri Oct 30 close$542.49you are here
- 52-wk highhighest close, 1 year$548.56+1.1%
Fair value estimate
How the range is computed
Financials model (residual income). Same residual-income model as the base: cost of equity 9.5% ±1 point and return on equity 11.7% ±2 points. Bear = 10.5% and 9.7%; bull = 8.5% and 13.7%. A model estimate from public filings, not a forecast of where the price will go.
Price sits inside the range.
What the price implies To be worth today’s price, BRK-B would need a return on equity of about 13% a year; our estimate uses 12%.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 30 to Oct 30, 252 sessions). Beta = how much BRK-B moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Has moved mostly independently of the market, with price swings about 1.1× the S&P 500’s.
- Beta vs S&P 500
- -0.04
- Volatility
- 15% vs 13% SPY
- Correlation SPY
- −0.03
- Correlation QQQ
- −0.19
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 3 of 5
ValuationPrice / book of 1.6×, below the 1.8× median for the 143 Finance companies we cover.
QualityPasses all four of our quality checks: cash generation, returns on capital, growth and balance sheet.
RiskCalmer than the market: beta −0.04 vs the S&P 500 and 15% yearly volatility (SPY 13%).
Top bearish points 5 of 5
ValuationOur residual-income fair value estimate is $478.54, 12% below the price.
ProfitabilityReturn on equity fell 8 points in two fiscal years, to 9% in FY2025.
GrowthSales grew 3.9% over the last 12 months, below the 11% median for the 142 Finance companies we cover.
GrowthSales grew 7.1% a year over the last three fiscal years, below the 9.3% median for the 144 Finance companies we cover.
ValuationTrades 5.6% above its Market Value of $513.87, the average price paid since the Aug 11 filing.
Who’s talking about it
Notable investors, executives, analysts and public figures on Berkshire Hathaway in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 1, 9:09 PM ET.
Compare with peers
Closest in size in Finance
All fundamentals
P/E 13.5 · ROE 12% · Sales +4%
Valuation
- P/E
- 13.5×Finance median 13.5×
- Price / FCF
- n/acash flow isn't a clean measure for an insurer
- FCF yield
- n/acash flow isn't a clean measure for an insurer
- EV / EBITDA
- n/anot meaningful for an insurer
- Price / sales
- 3.02×
- Price / book
- 1.55×
- Market cap
- $1.16Tprice × diluted shares
- Enterprise value
- n/anot reported in its SEC filings
Growth
- Revenue, 12 months
- $385B
- Sales growth, 12 months
- +3.9%vs the 12 months before
- Sales growth, 3 yrs
- +7.1%/yrfrom FY2022
- Diluted EPS, 12 months
- n/anot reported in its SEC filings
- EPS growth, last FY
- n/afewer than two years of diluted EPS
- Net income, 12 months
- $85.8B
- Net income growth
- +36%12 months vs before
Profitability
- Gross margin
- n/anot meaningful for an insurer
- Operating margin
- n/anot reported in its SEC filings
- Net margin
- 22.3%
- FCF margin
- 6.3%
- Return on equity
- 12%
- Return on invested capital
- n/anot meaningful for an insurer
Balance sheet
- Cash & short-term inv.
- $41.4B
- Total debt
- n/anot reported in its SEC filings
- Net cash
- n/anot meaningful for an insurer
- Debt / equity
- n/adeposits/float make debt/equity not comparable for an insurer
- Interest coverage
- n/anot meaningful for an insurer
Cash flow & returns
- Free cash flow, 12 months
- $24.2B
- FCF growth, 12 months
- +194%
- Dividend yield
- 0%
- Payout ratio
- n/anot reported in its SEC filings
- Buybacks, 12 months
- n/anot reported in its SEC filings
- Share count, 1 year
- n/ano quarterly diluted share count
- Stock-based comp
- n/anot reported in its SEC filings
Trailing 12 months to Jun 30, 2026; balance sheet at Jun 30, 2026. From Berkshire Hathaway’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
Valuation details
DCF $478.54 · MV $513.87
Financials model (residual income): book value $350.76 a share on Jun 30, 2026, plus the earnings above a 9.5% cost of equity. ROE 11.7%, the average of 12.1% for the trailing 12 months to Jun 30, 2026 and 11.4% over fiscal 2021–2025, on average common equity; payout 0% of earnings (dividends 0%), so book grows by the retained rest; the return above 9.5% fades halfway toward 9.5% over 10 years, then grows at 3% (terminal value). From the 10-Q filed Aug 10, 2026.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only arm once a company is in a dip.
Momentum & 52-week range
RSI 67 · 5 days +0.1%
The business
FCF $24.2B · Sales +42%
- Free cash flow, 12 months$24.2B
- Free-cash-flow yield2.0%
- Return on equity12%
- Sales growth (latest quarter vs year-ago quarter)+42%
Next report
Nov 6
- DateFri Nov 6
- Consensus EPS$5.91
- Year-ago EPS$6.26
- QuarterSep/2026
From Nasdaq’s earnings calendar. A report resets Market Value.
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.
Get a text when BRK-B fires a reversal signal
One text when a published rule fires on BRK-B or any of the 333 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.